FSD Pharma

1.43 -0.06 -4.03%
Stock Price | Oct. 22, 2021, 4 p.m.
Bid: 1.41
Ask: 1.47
Prev. Close: 1.49
52 Week Low: 1.28
52 Week High: 4.44
PE Ratio:
Dividend Yield: %

Company Summary

FSD Pharma Inc, through its wholly-owned subsidiary, is focused on Pharmaceutical research and development of its lead compound, FSD 201, ultra-micronized Palmitoyl ethylamine. The FSD 201 is known to stabilize mast cells of the human body and down-regulate the proinflammatory cytokines to effectuate an anti-inflammatory response.

Read more Read less

Recently Viewed Tickers